ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

AMSG Amsurg Corp.

67.75
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Amsurg Corp. NASDAQ:AMSG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 67.75 67.95 68.25 0 01:00:00

AmSurg Corp. Announces Completion of Exchange Offer For 5.625% Senior Notes Due 2022

19/02/2015 9:30pm

Business Wire


Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Amsurg Corp. Charts.

AmSurg Corp. (the “Company”) (NASDAQ: AMSG) today announced that it had completed its offer to exchange its 5.625% Senior Notes due 2022 in the aggregate principal amount of $1,100,000,000, which are not registered under the Securities Act of 1933, as amended (the “Act”) (the “private notes”), for a like principal amount of its 5.625% Senior Notes due 2022 (the “exchange notes”), which have been registered under the Act.

The exchange offer expired at 5:00 p.m. (New York City time) on February 18, 2015 (such time and date, the “Expiration Date”). As of the Expiration Date, $1,098,920,000 in aggregate principal amount (or 99.9%) of the outstanding private notes were validly tendered and accepted for exchange. The exchange offer was made pursuant to the registration rights agreement entered into in connection with the issuance of the private notes on July 16, 2014.

The terms of the exchange notes are substantially identical to the private notes, except that the exchange notes have been registered under the Act and are not subject to the transfer restrictions and certain registration rights agreement provisions applicable to the private notes. The sole purpose of the exchange offer was to fulfill the Company’s obligations with respect to the registration of the private notes.

This press release does not constitute an offer to sell or a solicitation of an offer to purchase securities. The exchange offer was made only pursuant to a prospectus dated January 16, 2015 and the related transmittal materials and only to such persons and in such jurisdictions as is permitted under applicable law.

About AmSurg Corp.

AmSurg Corp. operates an Ambulatory Services business that acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the U.S. AmSurg also operates a Physician Services business, Sheridan, that provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities, primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. Through these businesses as of September 30, 2014, AmSurg owned and operated 243 ASCs in 34 states and provided physician services in 25 states, employing more than 2,600 physicians and other healthcare professionals.

AmSurg Corp.Claire M. Gulmi, 615-665-1283Executive Vice President andChief Financial Officer

1 Year Amsurg Corp. Chart

1 Year Amsurg Corp. Chart

1 Month Amsurg Corp. Chart

1 Month Amsurg Corp. Chart

Your Recent History

Delayed Upgrade Clock